FRIDAY, May 12, 2023 (HealthDay News) -- Artificial intelligence (AI) can improve the design of surveillance programs for pancreatic cancer, according to a study published online May 8 in Nature Medicine. Davide Placido, from the University of Copenhagen in Denmark, and colleagues applied AI methods to clinical data from 6 million patients (24,000 cases of